So, at the threshold, the pharmacy would need to establish that i) it does not compound tirzepatide regularly or in inordinate amounts, and ii) its compounded tirzepatide is not merely a copy of Zepbound or Mounjaro
Meanwhile, patients on 1 mg, 1.7 mg, 2 mg and 2.4 mg injectable semaglutide had a median weight loss of 4.5%, 6%, 5.9% and 10%, respectively
While these medications can be very effective, not all patients achieve the maximum benefit from them and may still need surgery
Implications for Clinicians: Prescribing Considerations, Future Generics, and Drug Class Evolution Tirzepatide introduces a new era of incretin-based therapy , and clinicians play a key role in ensuring it is used safely and effectively